The common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug's cholesterol-lowering effects.
New research could help develop treatments for secondary progressive multiple sclerosis.
According to a new study, continued smoking after being diagnosed with multiple sclerosis can lead to an acceleration in the progression of the disease.
